July 19, 2012

Cover Story

CEO of the Year

Utah’s business landscape is rich with professionals who have le...Read More

Featured Articles

Did you go Skiing this winter?

Around Utah


Martin Plaehn

Karen Sendelback

Legal Briefs
Social Media and Employers: Friends or Enemies?

Money Talk
The Case for HSAs

Economic Insight
Time to Show Up

Lessons Learned
Make a Move

In the Lab

Rent to Own

Business Trends
Back from the Dead

Living Well
Artful Inspiration

A Breath of Fresh Air

Worst-Case Scenario

Regional Report
Northern Utah

Measure Up

Industry Outlook
Travel & Tourism



Idaho Technology Initiates Clinical Study for FilmArray Blood Culture Identification Panel

Press Release

July 19, 2012

Idaho Technology, Inc. announced it has commenced a clinical trial to evaluate the company's FilmArray Blood Culture Identification (BCID) Panel. The privately held clinical diagnostics company creates fast, high-quality instruments for pathogen identification and DNA analysis.

The panel is designed to identify the numerous organisms that can cause sepsis, as well as detect the presence of selected antibiotic resistance genes. The study is being conducted at several hospital-based clinical laboratories in the U.S. The FilmArray BCID will be the second clinical diagnostic test to run on Idaho Technology's FilmArray pathogen detection system.

CEO Kirk Ririe said, "Initiating clinical studies for our BCID panel brings us another step closer to being able to provide more comprehensive, actionable information which may help guide treatment decisions and improve patient outcomes. It also marks an important milestone in the expansion of our FilmArray clinical diagnostic test menu. Many of our existing FilmArray customers have expressed strong interest in using our BCID panel, based on the streamlined workflow and rapid results offered by our system. We believe the additional menu offering will accelerate adoption and utilization of FilmArray in global markets."

Idaho Technology anticipates the trial will run through the end of 2012 and expects to submit a 510(k) to the Food & Drug Administration (FDA) in early 2013. Pending FDA clearance, the company intends to launch FilmArray BCID commercially in the U.S. in the second quarter of 2013. The BCID panel will also be CE IVD-marked and offered for sale in the European Union in early 2013.

In parallel with the clinical study, Idaho Technology plans to offer select clinical laboratories limited access to FilmArray BCID as part of an investigational use only program. The purpose of this program is to familiarize current FilmArray users with the investigational BCID panel.

Utah Business Social
UB Events View All
Utah Employers Healthcare Summit and Healthcare Heroes Utah Business Event
Oct 6, 2015
The Utah Employers Healthcare Summit is a gathering of all of the major employers, healthcare pro...
Twenty in Their 20sUtah Business Event
Nov 5, 2015
Meet the young and ambitious professionals who are taking the business world by storm! The honore...
Sustainable Business Awards Utah Business Event
Nov 19, 2015
Utah Business magazine is pleased to announce the Utah Sustainable Business Awards. This program ...
Community Events View All
Oct 6, 2015
Link to tickets: https://www.eventbrite.com/e/secrets-to-financing-your-business-tickets-18611033...
Salt Lake City Sales Hiring Event
Oct 13, 2015
Salt Lake City Professional Career Event - Sales & Management Specific HireLive is a national ...

info@utahbusiness.com  |  90 South 400 West, Ste 650 Salt Lake City, Utah 84101   |  (801) 568-0114

Advertise with Utah Business

Submit an Event

* indicates required information
* Event Name:
Price (general):
Website (if applicable):
Coordinator's Name:
Coordinator's Email:
Coordinator's Phone:
Venue Name:
Venue Address:
Venue City:
Venue Zip:
Event Capacity:
* Event Description: